The DSV has three multimodal imaging platforms located within the Île-de-France (CEA-I2BM): MIRCen, Neurospin and the Service Hospitalier Frédéric Jolitot (SHFJ). This advanced group is involved in the national infrastructures in biology and health France Life Imaging and NeurATRIS. The three platforms are dedicated to translational research in such areas as neurodegenerative diseases, infectious diseases, cancer and cardiovascular diseases, thanks to in vivo models developed at the DSV.

Mircen

The preclinical imaging platform MIRCen (in Fontenay-aux-Roses) is a facility developed by the CEA and Inserm to design and evaluate innovative therapies, primarily for neurodegenerative and infectious diseases. Its teams have expertise in developing relevant animal models of human diseases and in imaging (MRI and PET), which allows them to evaluate new therapies and early markers of neurodegenerative diseases. MIRCen is certified by IBiSA.
Supervisor: Philippe HANTRAYE

neurospin

NeuroSpin (in Saclay) is the DSV’s one-of-a-kind center for high-field neuroimaging. It is at the same time a physics center for very high field MRI (11.7 teslas) and a clinical research center in the neurosciences. It closely couples the neuroimaging methodology with research applications in neurodegenerative diseases and the cognitive sciences. NeuroSpin is certified by IBiSA.
Supervisor: Denis LE BIHAN

Service hospitalier Frédéric Joliot

The SHFJ (in Orsay) is currently in Europe the only research structure integrated into a hospital to assemble different methods of functional and atraumatic exploration in humans (PET, MRI, SPECT, surface electroencephalography, etc.), all while maintaining basic research laboratories and a clinical unit in integrated nuclear medicine.
Supervisor: Badia Ourkia HELAL